News
AltaThera makes donation to the Humane Society of Tampa Bay
As part of a company retreat in Tampa, AltaThera donated $1,500 to the Humane Society of Tampa Bay.
As part of a company retreat in Tampa, AltaThera donated $1,500 to the Humane Society of Tampa Bay.
(Chicago, IL, November 26, 2025) – AltaThera Pharmaceuticals, a pharmaceutical company using innovative science to improve patient care and address serious and costly problems in
In July 2025, the U.S. Food and Drug Administration approved a label expansion for Sotalol IV, adding a new indication for pediatric patients with life-threatening ventricular arrhythmias and for the maintenance of normal sinus rhythm in atrial fibrillation and atrial flutter. This approval reflects AltaThera’s ongoing commitment to expanding access to personalized antiarrhythmic therapy for patients of all ages.